10-Q: Global Technologies Reports Q2 Loss Amid Strategic Shift

Sentiment:

Quarterly Report 20 February 2026 8:34 AM

📋All filings for Global Technologies LTD

Global Technologies, Ltd. reported a significant decline in revenue and a net loss for the six months ended December 31, 2025, as it navigates a strategic shift in its core health-tech operations.

Capital raiseThe company issued 200,000 shares of Series P Preferred Stock to an accredited investor for cash proceeds of $200,000 on August 24, 2025.Future plans include securing additional funding sources such as corporate partnerships, licensing revenue agreements, issuing additional convertible debentures, and issuing public or private equity securities, including through an at-the-market (ATM) facility.

Worse than expectedRevenue for the six months ended December 31, 2025, decreased by approximately 65.8% compared to the same period in 2024.Net income decreased by approximately 90.1% for the six months ended December 31, 2025, compared to the same period in 2024.The company shifted from generating cash from operating activities in 2024 to using a significant amount of cash in operating activities in 2025.The company explicitly states 'substantial doubt about our ability to continue as a going concern' due to a history of net losses and negative operating cash flows.Management reported that disclosure controls and procedures were not effective, citing material weaknesses.

Summary

Global Technologies, Ltd. (GTLL) reported a net income of $21,439 for the six months ended December 31, 2025, a substantial decrease from $217,352 in the same period of 2024.
Revenue for the six months ended December 31, 2025, was $541,293, down significantly from $1,586,508 in the prior year, primarily due to a strategic shift in the Primecare Supply subsidiary's operating focus.
The company transitioned from a wholesale procurement model (10 Fold Services) to a direct-to-clinic sales strategy through Primecare Supply, which management expects to yield higher margins and long-term value despite lower near-term revenue.
Operating expenses increased by 27.35% to $478,462 for the six months ended December 31, 2025, compared to $375,702 in the prior year.
Cash and cash equivalents decreased to $41,408 as of December 31, 2025, from $68,108 at June 30, 2025.
The company used $226,600 in cash from operating activities for the six months ended December 31, 2025, a shift from providing $98,489 in the prior year.
The acquisition of GOe3, LLC, an EV charging station developer, was terminated and cancelled on June 30, 2025, as it did not meet operational and financial milestones.
10 Fold Services, LLC ceased procurement operations in June 2025 due to changes in FDA regulations regarding GLP-1 products, transferring intellectual property to Primecare Supply.
GTLL Advisory Group, LLC (GloWell Advisors) was formed in May 2025 and is expected to commence revenue-generating operations in fiscal year 2026, focusing on strategic consulting for health and wellness businesses.
The company issued 200,000 shares of Series P Preferred Stock for $200,000 cash on August 24, 2025, with conversion rights, voting rights, a six-month lock-up, and revenue share distributions.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative report due to significant declines in revenue and net income, negative operating cash flow, explicit going concern uncertainty, and material weaknesses in internal controls, despite a stated strategic shift.

Positives

Total stockholders' deficiency improved, decreasing from $(1,153,279) at June 30, 2025, to $(931,840) at December 31, 2025.
The company successfully raised $200,000 through the issuance of Series P Preferred Stock in a private placement.
The strategic shift in Primecare Supply, LLC, from a wholesale model to a direct-to-clinic sales strategy, is expected to lead to higher gross margins, stronger free cash flow, and long-term shareholder value.
Primecare Supply, LLC has established contractual relationships with multiple 503B manufacturers, reseller partners, and hundreds of licensed medical clinics.
The termination of the GOe3, LLC acquisition allowed the company to reallocate resources toward its core health technology, procurement, and strategic advisory services segments.

Negatives

Revenue for the six months ended December 31, 2025, decreased significantly to $541,293 from $1,586,508 in the same period of 2024.
Net income for the six months ended December 31, 2025, decreased substantially to $21,439 from $217,352 in the same period of 2024.
The company experienced a shift from cash provided by operating activities ($98,489 in 2024) to cash used in operating activities ($(226,600) in 2025).
Cash and cash equivalents declined from $68,108 at June 30, 2025, to $41,408 at December 31, 2025.
Operating expenses increased by $102,760, or 27.35%, for the six months ended December 31, 2025, compared to the prior year.
The company has an accumulated deficit of $167,534,198 as of December 31, 2025, and a history of net losses.
Management concluded that disclosure controls and procedures were not effective as of December 31, 2025, citing material weaknesses due to resource constraints, lack of sufficient GAAP-knowledgeable personnel, absence of an audit committee, no independent outside directors, and insufficient documentation of internal control processes.

Risks

Substantial doubt exists about the company's ability to continue as a going concern due to a history of net losses and negative cash flows from operations.
Inability to effectively execute the business plan.
Challenges in managing expansion, growth, and operating expenses.
Difficulty in protecting brands and reputation.
Inability to repay existing debts.
Reliance on third-party suppliers, potentially outside the United States.
Challenges in evaluating and measuring business, prospects, and performance metrics.
Intense competition in the evolving industry.
Inability to respond and adapt to changes in technology and customer behavior.
Risks associated with completed or potential acquisitions, dispositions, and other strategic growth opportunities and initiatives, including integration risks.
Potential failure to preserve expertise in consumer product development.
Risk that existing and potential distribution partners may opt to work with competitors offering more favorable products or pricing.
Inability to maintain or grow sources of revenue and maintain profitability.
Challenges in attracting and retaining key personnel.
Inability to effectively manage or increase relationships with customers.
Unexpected increases in costs and expenses.
The company's business model depends on the availability of private funding.
General real estate risks and potential loss of investment in real estate properties if debt payments to note holders are not made.

Future Outlook

Management expects GTLL Advisory Group, LLC to commence revenue-generating operations in fiscal year 2026. The strategic shift in Primecare Supply, LLC, towards a direct-to-clinic sales strategy, is designed to generate more sustainable revenue, improved margins, stronger free cash flow, and long-term shareholder value as sales volumes scale and mature. The company plans to secure additional funding through corporate partnerships, licensing agreements, convertible debentures, and equity securities to address its going concern uncertainty.

Management Comments

Management believes Primecare Supply represents a core growth engine for Global Technologies, Ltd., offering scalable infrastructure, recurring transaction-based revenue, and a technology-enabled compliance advantage in the expanding health and wellness market.
Management expects GTLL Advisory to commence revenue-generating operations in fiscal year 2026 as part of Globals expanding health-technology and advisory services portfolio.
Management believes the decision to unwind the GOe3 acquisition allowed Global to reallocate resources toward its core business segments in health technology, procurement, and strategic advisory services.
Management believes the transition in Primecare Supply will result in slower near-term revenue growth but is designed to generate more sustainable revenue, improved margins, stronger free cash flow, and long-term shareholder value as sales volumes scale and mature.

Industry Context

StockSavvy.ai notes that Global Technologies' pivot towards health-tech and strategic advisory services, particularly in the pharmaceutical supply chain for 503B manufacturers, aligns with a growing demand for streamlined, compliant solutions in the health and wellness sector. The exit from the GLP-1 product market due to FDA regulatory changes highlights the inherent volatility and regulatory risks in specialized pharmaceutical distribution. The termination of the EV charging station venture (GOe3) indicates a strategic refocusing on core competencies, a common trend for diversified companies seeking to optimize resource allocation in competitive markets.

Comparison to Industry Standards

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Managing Director, Primecare Supply, LLC	NA	Fredrick K. Cutcher	2025-11-17	New executive employment agreement to support expansion of sales operations.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Disclosure Controls and Procedures	Management concluded that disclosure controls and procedures were not effective due to resource constraints, lack of sufficient GAAP-knowledgeable personnel, absence of an audit committee, no independent outside directors, and insufficient documentation of internal control processes.	2025-12-31	Indicates significant internal control weaknesses that could affect financial reporting reliability and compliance with SEC requirements.
Board Composition	The company does not have any independent outside directors on its Board of Directors.	NA	Raises concerns about oversight independence and corporate governance best practices.
Audit Committee	The company has not established an audit committee.	NA	Weakens financial oversight and internal control environment, potentially increasing risk of financial misstatement.

Legal Proceedings

No pending litigation involving the company at this time.

Related Party Transactions

Loans payable to officers/directors decreased from $100 at June 30, 2025, to $0 at December 31, 2025.

Stakeholder Impact

Shareholders face significant dilution risk from potential future equity raises and uncertainty regarding the company's ability to continue as a going concern.
Investors should be concerned about the substantial decline in revenue and net income, as well as the reported material weaknesses in internal controls.
Employees of Primecare Supply, LLC and GTLL Advisory Group, LLC may see opportunities for growth as the company focuses on these core segments, but overall company stability is a concern.
Customers of Primecare Supply, LLC may benefit from the direct-to-clinic sales strategy and diversified product offerings, but the company's financial health could impact long-term service reliability.
Creditors face increased risk due to the company's going concern uncertainty and history of net losses.

Next Steps

GTLL Advisory Group, LLC is expected to commence revenue-generating operations in fiscal year 2026.
The company plans to secure additional funding sources, including corporate partnerships, licensing revenue agreements, convertible debentures, and public or private equity securities (e.g., ATM facility).
The Board is seeking to improve controls and procedures to remediate identified material weaknesses in disclosure controls and internal control over financial reporting.

Key Dates

Date	Description
2021-01-20	Date of Convertible Promissory Note One payable to Tri-Bridge Ventures, LLC.
2021-01-27	Convertible Promissory Note One partially funded in the amount of $100,000.
2021-02-22	Date of Convertible Promissory Note Two payable to Tri-Bridge Ventures, LLC.
2021-03-02	Convertible Promissory Note Two funded.
2023-05-19	Jetco Holdings, LLC submitted a Notice of Conversion for Series L Preferred Stock into Class A Common Stock, later cancelled.
2023-11-22	10 Fold Services, LLC formed as a Wyoming limited liability company.
2024-03-15	Company acquired 100% ownership of GOe3, LLC via Share Exchange Agreement.
2024-05-31	Board of Directors approved the designation of Series N Preferred Stock.
2024-06-25	Company filed Certificate of Designations for Series N Preferred Stock.
2024-10-01	Effective date for the return of three shares of Series K Preferred Stock to the Company treasury by a former officer and director.
2024-10-22	Primecare Supply, LLC formed as a Wyoming limited liability company.
2024-11-22	Company entered into Executive Employment Agreement with H. Wyatt Flippen as CEO.
2025-02-02	Company issued 125,000 shares of Series N Preferred Stock to H. Wyatt Flippen.
2025-05-20	GTLL Advisory Group, LLC formed as a Wyoming limited liability company.
2025-06-25	10 Fold Services, LLC and its supplier mutually agreed to close all active contracts following changes in FDA regulations.
2025-06-30	Global elected to terminate and cancel the acquisition of GOe3, LLC and all related agreements.
2025-08-13	Primecare Supply, LLC entered into a lease agreement for a sales office in Tampa, Florida.
2025-08-20	Board of Directors approved the designation of Series P Preferred Stock.
2025-08-24	Company issued 200,000 shares of Series P Preferred Stock for $200,000 cash.
2025-09-05	Company filed Certificate of Designations for Series P Preferred Stock.
2025-09-15	Primecare Supply, LLC commenced occupancy of its Tampa sales office.
2025-11-17	Company entered into Executive Employment Agreement with Fredrick K. Cutcher as Managing Director of Primecare Supply, LLC.
2025-12-31	End of the quarterly period covered by this Form 10-Q.
2026-02-20	Filing date of the Form 10-Q and date of outstanding common stock count.

Recommendation

strong sell

The filing reveals a company in significant distress, marked by a substantial decline in revenue and net income, negative cash flow from operations, and an explicit 'going concern' warning. Material weaknesses in internal controls further erode investor confidence. While a strategic shift is underway, its positive impact is speculative and long-term, overshadowed by immediate financial deterioration and fundamental governance issues. The high risk of dilution from future capital raises and the overall instability make this a strong sell for any seasoned investor.

Keywords

Health Technology, Pharmaceutical Supply Chain, B2B Procurement, Wellness Clinics, Strategic Advisory, SEC Filing, Quarterly Report, Financial Performance, Going Concern, Internal Controls, Preferred Stock, GLP-1, Sinq Ops

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.